Corbus Pharmaceuticals Statistics
NASDAQ: CRBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
5.29-0.20 (-3.64%)
Market open · Delayed 15 min · as of Oct 8, 2:41 PM ET
Corbus Pharmaceuticals by the numbers
Corbus Pharmaceuticals has a market capitalization of $102.3 million based on 19.34M shares outstanding. With trailing EPS of $-6.11, Corbus Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 40.8% below its 50-day average and 40.8% below its 200-day average.
Average daily trading volume is 739.11K shares, or about $3.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CRBP valuation vs. peer median
| Metric | CRBP | Peer median | Difference |
|---|---|---|---|
| Market cap | $102.32M | $103.45M | -1% |
| Avg. volume | 739.11K | 288.93K | +156% |
Peer median across 8 companies: AARD, CPIX, SDEV, IMUX, KZIA, ANIX, RANI, UNCY.
Valuation
- Market cap
- $102.32M
- EPS (TTM)
- $-6.11
- Shares outstanding
- 19.34M
Price and trading
- Previous close
- 5.49
- Open
- 5.45
- Day range
- 5.14 – 5.52
- 52-week range
- 5.14 – 20.56
- 52-week change
- -62.42%
- Beta
- —
- Volume
- 886.39K
- Average volume
- 739.11K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2026
Additional statistics
- Market Cap
- 102.32M
- Forward Pe
- -0.96
- Eps
- -6.11
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 20.56
- Week52 Low
- 5.14
- Avg Volume
- 739.11K
- Shares Outstanding
- 19.34M
- Ma50
- 8.93
- Ma200
- 8.93
- Earnings Date
- Aug 6, 2026
- Pct From52w High
- -74.27%
- Pct From52w Low
- 2.92%